Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,715 | 133 | 95.1% |
| Education | $190.00 | 2 | 4.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Incyte Corporation | $313.19 | 12 | $0 (2024) |
| Astellas Pharma US Inc | $271.03 | 5 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $258.08 | 7 | $0 (2024) |
| Janssen Biotech, Inc. | $247.03 | 7 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $246.85 | 7 | $0 (2024) |
| Eisai Inc. | $214.07 | 10 | $0 (2024) |
| Gilead Sciences, Inc. | $210.77 | 6 | $0 (2024) |
| PUMA BIOTECHNOLOGY, INC. | $205.89 | 8 | $0 (2024) |
| Merck Sharp & Dohme LLC | $155.45 | 6 | $0 (2024) |
| SOBI, INC | $147.03 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,905 | 135 | Incyte Corporation ($313.19) |
All Payment Transactions
135 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Lilly USA, LLC | VERZENIO (Drug), JAYPIRCA | Food and Beverage | In-kind items and services | $20.38 | General |
| Category: Oncology | ||||||
| 12/19/2024 | ABBVIE INC. | ELAHERE (Drug) | Food and Beverage | In-kind items and services | $27.75 | General |
| Category: ONCOLOGY | ||||||
| 12/18/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $21.35 | General |
| Category: Oncology | ||||||
| 12/16/2024 | Incyte Corporation | MONJUVI (Drug), PEMAZYRE | Food and Beverage | Cash or cash equivalent | $18.87 | General |
| Category: Oncology | ||||||
| 12/16/2024 | Incyte Corporation | MONJUVI (Drug), PEMAZYRE | Food and Beverage | Cash or cash equivalent | $2.23 | General |
| Category: Oncology | ||||||
| 12/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | GILOTRIF (Drug) | Food and Beverage | In-kind items and services | $38.53 | General |
| Category: ONCOLOGY | ||||||
| 12/10/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Food and Beverage | In-kind items and services | $34.72 | General |
| Category: Oncology | ||||||
| 12/06/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $18.57 | General |
| 12/04/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: Oncology | ||||||
| 12/03/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological), ZEJULA | Food and Beverage | In-kind items and services | $25.17 | General |
| Category: ONCOLOGY | ||||||
| 12/02/2024 | PUMA BIOTECHNOLOGY, INC. | — | Food and Beverage | In-kind items and services | $27.96 | General |
| 11/26/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $23.54 | General |
| Category: Rare Disease | ||||||
| 11/25/2024 | Genentech USA, Inc. | Itovebi (Biological), Phesgo | Food and Beverage | In-kind items and services | $34.18 | General |
| Category: BioOncology | ||||||
| 11/18/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $25.53 | General |
| Category: Immunology | ||||||
| 11/11/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ICLUSIG (Drug) | Food and Beverage | In-kind items and services | $40.28 | General |
| Category: ONCOLOGY | ||||||
| 11/08/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological), ZEJULA | Food and Beverage | In-kind items and services | $29.08 | General |
| Category: ONCOLOGY | ||||||
| 11/08/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $22.41 | General |
| Category: Oncology | ||||||
| 11/05/2024 | Bayer Healthcare Pharmaceuticals Inc. | Stivarga (Drug) | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: Oncology | ||||||
| 11/05/2024 | Bayer Healthcare Pharmaceuticals Inc. | Stivarga (Drug) | Food and Beverage | In-kind items and services | $0.94 | General |
| Category: Oncology | ||||||
| 11/04/2024 | PUMA BIOTECHNOLOGY, INC. | — | Food and Beverage | In-kind items and services | $28.43 | General |
| 11/01/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $25.81 | General |
| Category: ONCOLOGY | ||||||
| 10/31/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $32.88 | General |
| Category: Oncology | ||||||
| 10/31/2024 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $28.70 | General |
| Category: Oncology | ||||||
| 10/30/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $34.73 | General |
| Category: ONCOLOGY | ||||||
| 10/25/2024 | ABBVIE INC. | ELAHERE (Drug) | Food and Beverage | In-kind items and services | $27.90 | General |
| Category: ONCOLOGY | ||||||
About Lanah Han
Lanah Han is a Nurse Practitioner healthcare provider based in Orange, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/26/2024. The National Provider Identifier (NPI) number assigned to this provider is 1427810290.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Lanah Han has received a total of $3,905 in payments from pharmaceutical and medical device companies, with $3,905 received in 2024. These payments were reported across 135 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($3,715).
Practice Information
- Specialty Nurse Practitioner
- Location Orange, CA
- Active Since 01/26/2024
- Last Updated 06/13/2025
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1427810290
Products in Payments
- Lenvima (Drug) $214.07
- Nubeqa (Drug) $204.99
- RYBREVANT (Drug) $190.40
- KEYTRUDA (Biological) $155.45
- EVENITY (Biological) $139.25
- Enhertu (Drug) $133.37
- VONJO (Drug) $124.58
- Trodelvy (Drug) $118.97
- JAKAFI (Drug) $106.73
- CABOMETYX (Drug) $96.04
- BRUKINSA (Drug) $92.22
- ULTOMIRIS (Biological) $81.09
- ENHERTU (Biological) $78.35
- ICLUSIG (Drug) $75.89
- FRUZAQLA (Drug) $69.00
- Onivyde (Drug) $66.44
- BESREMI (Drug) $64.99
- VERZENIO (Drug) $62.47
- GILOTRIF (Drug) $56.51
- ELAHERE (Drug) $55.65
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Orange
Sara Cooper, Acnp-Bc, ACNP-BC
Nurse Practitioner — Payments: $18,802
April Liwag, Np-C, NP-C
Nurse Practitioner — Payments: $12,872
Dixie Stiles, Np, NP
Nurse Practitioner — Payments: $9,122
John Trieu
Nurse Practitioner — Payments: $7,349
Cynthia Antonio, Np-C, NP-C
Nurse Practitioner — Payments: $6,770
Steven Bereta, Np, NP
Nurse Practitioner — Payments: $6,417